Free Trial

agilon health, inc. (NYSE:AGL) to Post Q2 2024 Earnings of ($0.08) Per Share, Leerink Partnrs Forecasts

→ Was the Great Financial Crisis fun? (From Brooks Enterprises) (Ad)
agilon health logo with Medical background

agilon health, inc. (NYSE:AGL - Free Report) - Research analysts at Leerink Partnrs dropped their Q2 2024 EPS estimates for shares of agilon health in a research report issued on Wednesday, May 8th. Leerink Partnrs analyst W. Mayo now expects that the company will earn ($0.08) per share for the quarter, down from their previous forecast of ($0.02). The consensus estimate for agilon health's current full-year earnings is ($0.34) per share. Leerink Partnrs also issued estimates for agilon health's Q3 2024 earnings at ($0.10) EPS, FY2024 earnings at ($0.34) EPS, Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.08) EPS, Q4 2025 earnings at ($0.19) EPS, FY2025 earnings at ($0.23) EPS, FY2026 earnings at $0.00 EPS, FY2027 earnings at $0.22 EPS and FY2028 earnings at $0.42 EPS.

Other equities analysts have also issued reports about the stock. Stifel Nicolaus cut their price target on shares of agilon health from $8.00 to $7.00 and set a "hold" rating on the stock in a report on Wednesday, May 1st. Truist Financial lowered their target price on shares of agilon health from $10.00 to $7.50 and set a "hold" rating for the company in a research note on Thursday, February 29th. TD Cowen lowered shares of agilon health from an "outperform" rating to a "market perform" rating and cut their price target for the company from $12.00 to $6.50 in a research note on Monday, February 26th. Citigroup assumed coverage on shares of agilon health in a research note on Monday, April 22nd. They set a "neutral" rating and a $6.00 price objective for the company. Finally, Evercore ISI dropped their price objective on shares of agilon health from $7.00 to $6.00 and set an "in-line" rating on the stock in a report on Wednesday, February 28th. One investment analyst has rated the stock with a sell rating, twelve have given a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat, agilon health has an average rating of "Hold" and a consensus price target of $9.32.


Check Out Our Latest Stock Analysis on agilon health

agilon health Stock Up 0.3 %

Shares of AGL stock traded up $0.01 during mid-day trading on Monday, hitting $5.21. 4,646,517 shares of the stock traded hands, compared to its average volume of 5,533,670. agilon health has a 52-week low of $4.41 and a 52-week high of $24.15. The stock's fifty day moving average is $5.28 and its two-hundred day moving average is $8.31. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.33 and a quick ratio of 1.33. The stock has a market cap of $2.14 billion, a P/E ratio of -7.44 and a beta of 0.52.

agilon health (NYSE:AGL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported ($0.41) EPS for the quarter, missing analysts' consensus estimates of ($0.28) by ($0.13). agilon health had a negative return on equity of 26.15% and a negative net margin of 5.67%. The business had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.02 billion. During the same period last year, the firm earned ($0.14) EPS. The business's quarterly revenue was up 71.8% on a year-over-year basis.

Institutional Trading of agilon health

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Signaturefd LLC grew its holdings in shares of agilon health by 73.7% during the third quarter. Signaturefd LLC now owns 1,673 shares of the company's stock worth $30,000 after buying an additional 710 shares in the last quarter. Quest Partners LLC purchased a new position in shares of agilon health during the 4th quarter worth $45,000. Neo Ivy Capital Management purchased a new position in shares of agilon health during the 4th quarter worth $47,000. Simplicity Wealth LLC acquired a new position in shares of agilon health during the 1st quarter valued at about $65,000. Finally, Bleakley Financial Group LLC purchased a new stake in shares of agilon health in the first quarter valued at about $65,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Further Reading

Earnings History and Estimates for agilon health (NYSE:AGL)

Should you invest $1,000 in agilon health right now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Profit Like Congress: The Stocks They’re Betting On
Cathie Wood’s AMD Buy: Smart Move or Risky Business
4 of the Best Stocks for Share Buybacks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines